Using genetic testing to improve cancer prevention in older adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data from individuals aged 65 and older to evaluate the benefits of hereditary cancer genomic diagnostics in assessing genetic cancer risk. The study focuses on guiding physicians in implementing preventative measures that may lead to early detection and treatment of cancer. Participants must have a medical necessity for genetic testing, which will be ordered by their physician based on individual care considerations. The genes evaluated may change over time as new information becomes available, ensuring that the testing remains relevant and comprehensive.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Study subjects may be included in the Clinical Trial if they meet all of the following inclusion criteria:

  * individuals, ages 65 years or older;
  * must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity;
  * hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations.
  * study subject has or had cancer
  * study subject has at least one family member with cirrent or past cancer

Exclusion Criteria:

* Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;

  * study subject is unable to provide an accurate history due to mental incapacity
  * study subject is currently abusing illicit and/or prescription drugs;

Where it's running

• Sunbeam Clinical
  Prosper, Texas, United States Recruiting

Study contacts

• Study coordinator: C David, MBA
• Email: stopcancer@callmdglobal.com
• Phone: 7174671201

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Methylation markers in self-samples to help detect gynecological cancers

  This study tests whether self-collected urine and vaginal samples can reveal DNA methylation or other genetic markers that indicate endometrial, ovarian, vulvar, or vaginal cancers in women who are at risk or have postmenopausal bleeding.

  Recruiting Universiteit Antwerpen · Edegem, Antwerp · NCT07902375

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• Empowering patients to get lung cancer screening with support and navigation

  This pilot study tests a patient navigation and education program to see if it helps adults who are eligible start and complete low-dose CT lung cancer screening.

  Recruiting at 13 sites University of California, Irvine · Anaheim, California and 56 other locations · NCT07711691

• Breast ultrasound screening for older women in community clinics

  This study tests whether offering breast ultrasound to women aged 65–80 in local communities helps find breast cancers earlier than usual care.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Kunshan, Jiangsu and 1 other locations · NCT07698366

• Text reminders to boost colorectal cancer screening participation

  A large group of people aged 50–69 in Vallès Occidental will be randomised to receive a reminder text message five weeks after an initial invitation, to see if it increases uptake of the FIT screening compared with the standard postal letter.

  Recruiting Corporacion Parc Tauli · Sabadell, Catalonia · NCT07628998

• Menstrual cup for early detection of endometrial cancer in Lynch syndrome

  This project will test whether using a menstrual cup can collect uterine lining samples that help detect early endometrial cancer in menstruating people who carry Lynch syndrome gene changes.

  Recruiting Brigham and Women's Hospital · Boston, Massachusetts · NCT07220239

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.